Imricor Medical Systems Inc (IMR) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.853x

Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has a cash flow conversion efficiency ratio of -0.853x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.84 Million ≈ $-6.96 Million USD) by net assets (AU$11.53 Million ≈ $8.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See IMR net asset quality index to measure how much of total assets are equity-financed.

Imricor Medical Systems Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Imricor Medical Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore Imricor Medical Systems Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.

Imricor Medical Systems Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imricor Medical Systems Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shandong Daye Co Ltd Class A
SHG:603278
0.074x
Joyware Electronics Co Ltd
SHE:300270
-0.015x
Hefei Taihe Optoelectronic
SHG:603656
0.052x
TUNGSTEN WEST PLC LS -01
F:540
N/A
Healthcare Co Ltd
SHG:603313
0.109x
Duta Pertiwi Tbk
JK:DUTI
0.009x
ShenZhen Zero-Seven Co Ltd
SHE:000007
0.554x
AnShan Heavy Duty Mining Machinery Co Ltd
SHE:002667
0.106x

Annual Cash Flow Conversion Efficiency for Imricor Medical Systems Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of Imricor Medical Systems Inc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Imricor Medical Systems Inc.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 AU$11.53 Million
≈ $8.16 Million
AU$-19.75 Million
≈ $-13.97 Million
-1.712x -181.12%
2024-12-31 AU$-7.38 Million
≈ $-5.22 Million
AU$-15.57 Million
≈ $-11.02 Million
2.111x +42.40%
2023-12-31 AU$-8.75 Million
≈ $-6.19 Million
AU$-12.98 Million
≈ $-9.18 Million
1.483x +167.44%
2022-12-31 AU$7.51 Million
≈ $5.31 Million
AU$-16.51 Million
≈ $-11.68 Million
-2.198x -181.58%
2021-12-31 AU$22.40 Million
≈ $15.85 Million
AU$-17.49 Million
≈ $-12.37 Million
-0.781x -83.94%
2020-12-31 AU$28.82 Million
≈ $20.39 Million
AU$-12.23 Million
≈ $-8.65 Million
-0.424x +54.96%
2019-12-31 AU$7.03 Million
≈ $4.98 Million
AU$-6.63 Million
≈ $-4.69 Million
-0.942x -100.20%
2018-12-31 AU$13.47 Million
≈ $9.53 Million
AU$-6.34 Million
≈ $-4.49 Million
-0.471x -143.77%
2017-12-31 AU$-5.25 Million
≈ $-3.72 Million
AU$-5.65 Million
≈ $-4.00 Million
1.075x +6.98%
2016-12-31 AU$-4.03 Million
≈ $-2.85 Million
AU$-4.05 Million
≈ $-2.87 Million
1.005x --

About Imricor Medical Systems Inc

AU:IMR Australia Medical Devices
Market Cap
$465.07 Million
AU$657.29 Million AUD
Market Cap Rank
#12467 Global
#326 in Australia
Share Price
AU$1.86
Change (1 day)
+0.00%
52-Week Range
AU$1.27 - AU$2.20
All Time High
AU$2.79
About

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatib… Read more